Pablo Wicke-Delgado

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection.

Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection.

Journal: Frontiers in immunology

Published: September 26, 2025

Correction: Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.

Correction: Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.

Journal: Cellular and molecular life sciences : CMLS

Published: October 14, 2024

Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.

Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.

Journal: Scientific reports

Published: December 14, 2023

Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.

Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.

Journal: Cellular and molecular life sciences : CMLS

Published: July 26, 2023

MAFB shapes human monocyte-derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression.

MAFB shapes human monocyte-derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression.

Journal: JCI insight

Published: June 09, 2023

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Journal: Frontiers in medicine

Published: May 07, 2023

Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.

Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.

Journal: Hematological oncology

Published: April 18, 2023

MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity.

MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity.

Journal: The EMBO journal

Published: February 08, 2023

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity.

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity.

Journal: Life science alliance

Published: June 02, 2022

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

Journal: Life science alliance

Published: January 31, 2022

TYK2 Variants in B-Acute Lymphoblastic Leukaemia.

TYK2 Variants in B-Acute Lymphoblastic Leukaemia.

Journal: Genes

Published: October 05, 2020

Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells.

Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells.

Journal: Cancers

Published: January 31, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026